ECSP993095A - 1-aril-3- arilmetil -8 -naftiridin -4 (1h)-(onas) - Google Patents

1-aril-3- arilmetil -8 -naftiridin -4 (1h)-(onas)

Info

Publication number
ECSP993095A
ECSP993095A ECSP993095A ECSP993095A EC SP993095 A ECSP993095 A EC SP993095A EC SP993095 A ECSP993095 A EC SP993095A EC SP993095 A ECSP993095 A EC SP993095A
Authority
EC
Ecuador
Prior art keywords
aryl
respiratory
disease
naftiridin
onas
Prior art date
Application number
Other languages
English (en)
Inventor
Edward Fox Kleinman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP993095 priority Critical patent/ECSP993095A/es
Publication of ECSP993095A publication Critical patent/ECSP993095A/es

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Un compuesto de fórmula (gráfico), o la sal farmacéuticamente aceptable del mismo, en la que R1, R2 y R3 son como se han definido anteriormente, útil en el tratamiento de trastornos respiratorios, alérgicos, reumatoides, de regulación del peso corporal, inflamatorios y del sistema nerviosos central, tales como asma, enfermedad pulmonar obstructiva crónica, síndrome de enfermedades respiratorias en adultos, choque tóxico, fibrosis, hipersensibilidad pulmonar, rinitis alérgica, dermatitis atópica, psoriasis, control de peso, artritis reumatoide caquexia, enfermedad de Crohn, colitis ulcerosa, afecciones artriticas y otras enfermedades inflamatorias, depresión, demencia multiinfarto y SIDA.
ECSP993095 1999-08-11 1999-08-11 1-aril-3- arilmetil -8 -naftiridin -4 (1h)-(onas) ECSP993095A (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP993095 ECSP993095A (es) 1999-08-11 1999-08-11 1-aril-3- arilmetil -8 -naftiridin -4 (1h)-(onas)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP993095 ECSP993095A (es) 1999-08-11 1999-08-11 1-aril-3- arilmetil -8 -naftiridin -4 (1h)-(onas)

Publications (1)

Publication Number Publication Date
ECSP993095A true ECSP993095A (es) 1999-10-06

Family

ID=42044082

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP993095 ECSP993095A (es) 1999-08-11 1999-08-11 1-aril-3- arilmetil -8 -naftiridin -4 (1h)-(onas)

Country Status (1)

Country Link
EC (1) ECSP993095A (es)

Similar Documents

Publication Publication Date Title
BR9810733A (pt) Derivados de nicotinamida
SV1999000120A (es) 1-aril-3-arilmetil-1,8-naftiridin-4 (1h)-onas ref. pc10020/82739/bb
EP1541574A4 (en) TRIAZASPIRO DERIVATIVES 5.5 | UNDECANS AND DRUGS CONTAINING THEM AS AN ACTIVE INGREDIENT
ECSP055768A (es) Derivados de azol-pirimidina condensados
TNSN07098A1 (en) 2,6- substituted -4- monosubstitutedamino-pyrimidine as prostaglandin d2 receptor antagonists
NO20075696L (no) Nanopartikulaere preparater for kontrollert frigjoring omfattende syklosporin
WO2007114848A3 (en) Chemical compounds
TNSN08131A1 (en) Dihydrogen phosphate salt of a prostaglandin d2 receptor antagonist
PL372466A1 (en) Carboxylic acid compounds and drugs containing the compounds as the active ingredient
TW200639151A (en) 2-phenyl-indoles as prostaglandin D2 receptor antagonists
AR062051A1 (es) 2-fenilindoles como antagonistas del receptor de la prostaglandina d₂
AR060403A1 (es) Compuestos de amino- pirimidina 2,6- sustituidos -4- monosustituidos como antagonistas del receptor de prostaglandina d2
WO2006085212A3 (en) Condensed isoxaline derivatives as inhibitors of phosphodiesterase type-iv
ECSP993095A (es) 1-aril-3- arilmetil -8 -naftiridin -4 (1h)-(onas)
WO2005051931A3 (en) Phosphodiesterase inhibitors
EP1666473A4 (en) CARBOXYLIC ACID COMPOUNDS AND MEDICINAL COMPOSITIONS CONTAINING THE SAME AS ACTIVE INGREDIENT
ECSP982468A (es) Derivados de nicotinamida
WO2017126700A9 (ja) 小胞型ヌクレオチドトランスポーター活性阻害剤
JP2006502171A5 (es)
WO2002048397A3 (en) Regulation of human adenylate cyclase, type vii
WO2006089658A3 (en) Nk1 antagonists
Goto et al. Effect of the Adjustment of the Tibiofibular Joint on the Range of Motion in the Ankle Joint and Exercise Performance
DOP2003000724A (es) Derivados de azol-pirimidina condensados
TH43442A (th) อนุพันธ์นิโคตินเอไมด์